Patents by Inventor Erik Berntorp

Erik Berntorp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENETIC FACTORS ASSOCIATED WITH INHIBITOR DEVELOPMENT IN HEMOPHILIA A
    Publication number: 20180016635
    Abstract: The present invention provides methods for predicting the risk of an individual developing antibodies to factor VIII by identifying a single nucleotide polymorphism of an immune response or immune modifier gene. The invention further provides oligonucleotides, diagnostic kits, microarrays, and isolated nucleic acids comprising single nucleotide polymorphisms of immune response or immune modifier genes.
    Type: Application
    Filed: March 14, 2017
    Publication date: January 18, 2018
    Inventors: Jan Astermark, Erik Berntorp
  • Genetic factors associated with inhibitor development in hemophilia A
    Patent number: 9644239
    Abstract: The present invention provides methods for predicting the risk of an individual developing antibodies to factor VIII by identifying a single nucleotide polymorphism of an immune response or immune modifier gene. The invention further provides oligonucleotides, diagnostic kits, microarrays, and isolated nucleic acids comprising single nucleotide polymorphisms of immune response or immune modifier genes.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: May 9, 2017
    Inventors: Jan Astermark, Erik Berntorp
  • Genetic factors associated with inhibitor development in hemophilia A
    Patent number: 9637789
    Abstract: The present invention provides methods for predicting the risk of an individual developing antibodies to factor VIII by identifying a single nucleotide polymorphism of an immune response or immune modifier gene. The invention further provides oligonucleotides, diagnostic kits, microarrays, and isolated nucleic acids comprising single nucleotide polymorphisms of immune response or immune modifier genes.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: May 2, 2017
    Assignee: Jan Astermark and Erik Berntorp
    Inventors: Jan Astermark, Erik Berntorp
  • GENETIC FACTORS ASSOCIATED WITH INHIBITOR DEVELOPMENT IN HEMOPHILIA A
    Publication number: 20120065077
    Abstract: The present invention provides methods for predicting the risk of an individual developing antibodies to factor VIII by identifying a single nucleotide polymorphism of an immune response or immune modifier gene. The invention further provides oligonucleotides, diagnostic kits, microarrays, and isolated nucleic acids comprising single nucleotide polymorphisms of immune response or immune modifier genes.
    Type: Application
    Filed: August 10, 2011
    Publication date: March 15, 2012
    Inventors: Jan Astermark, Erik Berntorp
  • GENETIC FACTORS ASSOCIATED WITH INHIBITOR DEVELOPMENT IN HEMOPHILIA A
    Publication number: 20110312519
    Abstract: The present invention provides methods for predicting the risk of an individual developing antibodies to factor VIII by identifying a single nucleotide polymorphism of an immune response or immune modifier gene. The invention further provides oligonucleotides, diagnostic kits, microarrays, and isolated nucleic acids comprising single nucleotide polymorphisms of immune response or immune modifier genes.
    Type: Application
    Filed: April 21, 2011
    Publication date: December 22, 2011
    Inventors: Jan Astermark, Erik Berntorp